Validity and usefulness of a single‐item measure of patient‐reported bother from side effects of cancer therapy
Validity and usefulness of a single‐item measure of patient‐reported bother from side effects of cancer therapy
BACKGROUND The improving efficacy of cancer treatment has resulted in an increasing array of treatment‐related symptoms and associated burdens imposed on individuals undergoing aggressive treatment of their disease. Often, clinical trials compare therapies that have different types, and severities, of adverse effects. Whether rated by clinicians or patients themselves, it …